Meet the Investigator: Namrata Singh

Share on social media

Namrata Singh, MD, MSCI, FACP 

University of Washington 

Investigator Award

Impact of Early Therapy with Tumor Necrosis Factor Inhibitors on Lymphoma Risk in Patients with Rheumatoid Arthritis

Dr. Singh says patients often ask about risks such as cancer that might be associated with the drugs they are taking.

“Hopefully the data we provided with part of the Rheumatology Research Foundation funded-project will help guide these discussions in real time. “

To hear more from Dr. Singh, watch the video above.

Donors like you make our important research funding possible. Consider donating today.